Can a Potassium Binder Slow the Progression of CKD?

According to Healio, a web platform offering daily clinical news, peer-reviewed journals, and continuing medical education (CME) in more than 30 medical specialties, a study suggests that long-term use of a medication called patiromer may help slow the progression of chronic kidney disease (CKD) in people with high levels of potassium in their blood (hyperkalemia). Read the article - Long-term use of potassium binder patiromer may slow progression of CKD.

What is patiromer?
Patiromer is a medicine that helps to lower potassium levels in the blood. It is often used by people with chronic kidney disease (CKD) who have high potassium levels.

What did the study find?
A new study found that people with CKD who take patiromer for a long time may be less likely to need dialysis or die than people who don't take patiromer. The study also found that people who take patiromer for a long time may be less likely to die from any cause.

What does this mean for patients?
This study is good news for people with CKD who have high potassium levels. It suggests that patiromer may help to slow the progression of CKD and improve overall survival. However, more research is needed to confirm these findings.

What are the next steps?
More research is needed to confirm these findings and to determine the optimal duration of patiromer treatment. Patients with CKD should talk to their doctor about whether patiromer is right for them.

Please note: This is not a substitute for medical advice. Please talk to your doctor about your individual circumstances.

Source: Healio Nephrology News & Issues